YOLFTbeta
Caring Brands, Inc. Common Stock

Caring Brands, Inc. Common Stock

CABR · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

0.8046USD+0.00 (+0.04%)

Price History

Full chart

Market Stats

Previous Close0.8043
Open0.83
Day Range0.7848 – 0.8792
52-Week Range0.7102 – 6.00
Volume60.79K
Market Cap12.60M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.78
Dividend Yield0.00%
50-Day Avg1.36
200-Day Avg1.13

About

Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema). The company also offers NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics, as well as provides vitiligo solutions and women's sexual wellness products. Caring Brands, Inc., was incorporated in 2020 and is based in Fort Pierce, Florida.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOPaul Jones
  • Employees3
  • Headquarters130 S Indian River Drive, Fort Pierce, FL, United States, 34950, USA
  • Websitehttps://www.Caringbrands.com

Leadership

  • Paul JonesOperations Manager

Financials

Income Statement

Currency: USD2023-12-312024-12-312025-12-31
Total Revenue20.42K4654.21K
Growth (%)--97.72%+806.45%
Cost of Revenue118.87K2.07K1.87K
Gross Profit-98.45K-1.61K2.34K
Gross Margin-482.12%-345.59%55.56%
Operating Expense52.94K1.53M5.94M
Operating Income-151.39K-1.53M-5.94M
Operating Margin-741.36%-328471.83%-140807.24%
EBITDA---5.31M
EBITDA Margin---126002.97%
Net Income-128.09K-1.52M-6.28M
Net Income Margin-627.23%-326329.25%-148948.78%
Interest Expense--19.17K
Interest Expense % of Total Revenue--454.71%

Balance Sheet

Currency: USD2023-12-312024-12-312025-12-31
Total Assets22.91K3.88M2.33M
Total Liabilities288.69K186.10K235.49K
Total Equity-265.77K3.69M2.09M
Cash18.16K469.00K2.19M
Total Debt--58.65K
Net Debt248.79K--2.13M

Cash Flow

Currency: USD2023-12-312024-12-312025-12-31
Operating Cash Flow-58.63K-823.99K-1.69M
Financing Cash Flow15.39K666.23K3.41M
Capital Expenditure000
Free Cash Flow-58.63K-823.99K-1.69M
FCF to OCF100.00%100.00%100.00%

Earnings

Report DateMar 20, 2025Aug 21, 2025Nov 14, 2025Aug 13, 2026Nov 13, 2026
EPS Estimate0.000.000.00--
EPS Actual-0.05-0.09-0.08-0.10-
Surprise-----
Timing-----

Key Statistics & Ratios

Market Cap12.60M
Enterprise Value10.83M
Trailing P/E0.00
Forward P/E0.00
Price / Sales10869.19
Price / Book4.03
EPS-0.78
Book Value-0.298
Revenue (TTM)1.16K
Gross Profit (TTM)686
EBITDA-4.25M
Profit Margin0.00%
Operating Margin-392263.60%
Return on Equity-333.74%
Return on Assets-108.32%
Shares Outstanding10.37M
Shares Float2.47M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
1.52%
Insiders
18.81%
Retail / Other
79.67%

Top Institutional Holders

  • Wells Fargo & Co
    72.43K0.80%
  • Geode Capital Management, LLC
    58.83K0.65%
  • Jane Street Group LLC
    35.67K0.39%
  • XTX Topco Ltd
    20.77K0.23%
  • Vanguard Capital Management, LLC
    17.25K0.19%
  • Tower Research Capital LLC
    4780.01%
  • Virtu Financial LLC
    00.00%
  • Bank of America Corp
    00.00%
  • HRT FINANCIAL LLC
    00.00%
  • UBS Group AG
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    16.27K0.16%
  • Fidelity Series Total Market Index
    5.80K0.06%